---
title: "Autobio's subsidiary obtains medical device registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238225289.md"
description: "According to the Zhitong Finance APP, Autobio announced that its wholly-owned subsidiary Beijing Autobio Engineering Co., Ltd. recently received a medical device registration certificate issued by the Beijing Municipal Medical Products Administration, involving the following products: \"Lambda (λ-LC) Light Chain Determination Kit (Immunoturbidimetric Method)\", \"Kappa (κ-LC) Light Chain Determination Kit (Immunoturbidimetric Method)\", and \"Immunoglobulin G4 (IgG4) Determination Kit (Latex Immunoturbidimetric Method)\""
datetime: "2025-04-30T08:09:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238225289.md)
  - [en](https://longbridge.com/en/news/238225289.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238225289.md)
---

# Autobio's subsidiary obtains medical device registration certificate

According to the announcement from Zhitong Finance APP, Autobio (603658.SH) has stated that its wholly-owned subsidiary, Beijing Autobio Biotechnology Co., Ltd., recently received a medical device registration certificate issued by the Beijing Municipal Medical Products Administration. The products involved are: "Lambda (λ-LC) Light Chain Assay Kit (Immunoturbidimetric Method)", "Kappa (κ-LC) Light Chain Assay Kit (Immunoturbidimetric Method)", and "Immunoglobulin G4 (IgG4) Assay Kit (Latex Immunoturbidimetric Method)"

### Related Stocks

- [603658.CN](https://longbridge.com/en/quote/603658.CN.md)

## Related News & Research

- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [10:45 ETInventHelp Inventor Develops New Illuminated Display (SGM-649)](https://longbridge.com/en/news/286933598.md)
- [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md)
- [BCAL Diagnostics Expands National Access to Early Cancer Detection Blood Tests](https://longbridge.com/en/news/286850851.md)
- [Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities | DTCFF Stock News](https://longbridge.com/en/news/286870222.md)